Table 3 Comorbidities age distribution with end-stage knee osteoarthritis
From: Clinical phenotypes of comorbidities in end-stage knee osteoarthritis: a cluster analysis
Characteristic | Age Segments (years) | P Value | ||
|---|---|---|---|---|
< 60 | 60–70 | > 70 | ||
N | 51 | 234 | 136 | - |
Demographics | ||||
BMI (kg/m2) | 24.9 ± 2.9 | 25.4 ± 3.3 | 25.3 ± 3.7 | 0.388 |
Female gender | 41 (80) | 192 (82) | 101 (74) | - |
Waist circumference (cm) | 87.7 ± 8.7 | 90.0 ± 9.0 | 90.0 ± 10.3 | 0.115 |
Comorbidity | ||||
Obesity | 13 (26) | 63 (27) | 37 (27) | 0.972 |
Hypertension | 24 (47) | 112 (48) | 84 (62) | 0.026 |
Diabetes | 11 (22) | 53 (23) | 33 (24) | 0.906 |
Coronary heart disease | 2 (4) | 39 (17) | 29 (21) | 0.010* |
Hyperuricemia | 4 (8) | 22 (9) | 14 (10) | 0.916* |
Stroke | 5(10) | 15(6) | 23(17) | 0.006 |
Rheumatoid arthritis | 5(10) | 16(7) | 4(3) | 0.130* |
Chronic renal disease | 0(0) | 1(0) | 3(2) | 0.175* |
Liver disease | 14(28) | 69(30) | 40(29) | 0.957 |
Sleep disorders | 7(14) | 18(8) | 15 (11) | 0.314 |
Depression | 19 (37) | 80 (34) | 44 (32) | 0.815 |
Anxiety | 15 (30) | 58 (25) | 36 (27) | 0.778 |
Hyperlipidemia | 6(12) | 34(15) | 19(14) | 0.875 |